DMTK

DermTech, Inc.

0.15 USD
+0.01 (+3.78%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

DermTech, Inc. stock is down -58.06% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 71.43% of the previous 6 June’s closed higher than May.

About DermTech, Inc.

DermTech, Inc. develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners.